The leading conference on anti-microbial resistance

 

Learn more about the leading conference on antimicrobial resistance

Antimicrobial Resistance Congress is set to be the most strategic AMR conference globally. Get involved now to showcase your solutions to  government authorities, pharma & biotech.

If your organization is working in the infectious disease space and has a solution to curb anti-microbial resistance, then you should be a part of the World Anti-Microbial Resistance Congress 2018!

DOWNLOAD SPONSORSHIP BROCHURE

SIGN UP FOR EVENT UPDATES

"Very well organized. Perfect number of attendees and the right mix of policy makers, industry, scientists and clinicians. Enables free flow of ideas and actionable items."

-- Director of Antimicrobial Stewardship and Infectious Diseases, Medical Specialties, University of Florida College of Medicine

 

2017 SPEAKERS INCLUDED

 

  • Ritu Banerjee at World Anti-Microbial Resistance Congress 2017
    Ritu Banerjee
    Associate Professor of Pediatrics
    Vanderbilt Antimicrobial Stewardship Program (VASP)
    Oren Cohen at World Anti-Microbial Resistance Congress 2017
    Oren Cohen
    Chief Medical Officer
    Viamet Pharmaceuticals
    Timothy Cooke at World Anti-Microbial Resistance Congress 2017
    Timothy Cooke
    Chief Executive Officer
    NovaDigm Therapeutics
  • Ian Critchley at World Anti-Microbial Resistance Congress 2017
    Ian Critchley
    VP Clinical Microbiology
    Allergan Pharmaceuticals Inc
    Enea Di Domenico at World Anti-Microbial Resistance Congress 2017
    Enea Di Domenico
    Clinical Pathology and Microbiology
    Istituti Fisioterapici Ospitalieri
    Michael Draper at World Anti-Microbial Resistance Congress 2017
    Michael Draper
    Extneral Innovation
    Sanofi
  • Michael Dudley at World Anti-Microbial Resistance Congress 2017
    Michael Dudley
    Senior Vice President, Head of R&D Co-Lead, Infectious Disease Global Innovation
    The Medicines Company
    Scott Evans at World Anti-Microbial Resistance Congress 2017
    Scott Evans
    Director, Statistical and Data Management Center (SDMC) for the Antibacterial Resistance Leadership Group (ARLG)
    Harvard University
    Jean-Marc Ghigo at World Anti-Microbial Resistance Congress 2017
    Jean-Marc Ghigo
    Head of Genetics of Biofilms Lab
    Institut Pasteur
  • Debra Goff at World Anti-Microbial Resistance Congress 2017
    Debra Goff
    Infectious Diseases Specialist,The Ohio State University Wexner Medical Center Clinical Associate Professor
    The Ohio State University Medical Center
    Keith Hamilton at World Anti-Microbial Resistance Congress 2017
    Keith Hamilton
    Director, Antimicrobial Stewardship Program
    Hospital of the University of Pennsylvania
    Evan Hecker at World Anti-Microbial Resistance Congress 2017
    Evan Hecker
    Director of API Development
    Spero Therapeutics LLC
  • Elizabeth Hermsen at World Anti-Microbial Resistance Congress 2017
    Elizabeth Hermsen
    Head, Global Antimicrobial Stewardship
    Merck & Co., Inc.
    Lauri Hicks at World Anti-Microbial Resistance Congress 2017
    Lauri Hicks
    Director, Office of Antibiotic Stewardship, Division of Healthcare Quality Promotion
    Centers for Disease Control & Prevention
    Chris Houchens at World Anti-Microbial Resistance Congress 2017
    Chris Houchens
    PhD, Branch Chief (Acting), Antibacterials Program
    BARDA
  • Romney Humphries at World Anti-Microbial Resistance Congress 2017
    Romney Humphries
    Section Chief,Clinical Microbiology
    Ucla Health System University of California Los Angeles
    Deborah Hung at World Anti-Microbial Resistance Congress 2017
    Deborah Hung
    Director of Infectious Disease Program
    Broad Institute of M.I.T. & Harvard
    Peter Jackson at World Anti-Microbial Resistance Congress 2017
    Peter Jackson
    CEO
    The AMR Centre UK
  • Lee Jones at World Anti-Microbial Resistance Congress 2017
    Lee Jones
    Founder, President and Chief Executive Officer
    Rebiotix, Inc.
    Adrian Jubb at World Anti-Microbial Resistance Congress 2017
    Adrian Jubb
    Vice President and Head of Early Development
    Achaogen
    Jane Knisely at World Anti-Microbial Resistance Congress 2017
    Jane Knisely
    Program Officer, Bacteriology and Mycology Branch, NIAID
    NIH - NIAID & University of Kansas
  • Sophia Koo at World Anti-Microbial Resistance Congress 2017
    Sophia Koo
    Assistant Professor of Medicine
    Harvard Medical School
    Nicole Mahoney at World Anti-Microbial Resistance Congress 2017
    Nicole Mahoney
    Director, Global Regulatory Policy
    Merck
    Valerie Oriol Mathieu at World Anti-Microbial Resistance Congress 2017
    Valerie Oriol Mathieu
    Global Medical Affairs Lead, Vaccines
    Janssen Vaccines & Prevention
  • Andrew McCandlish at World Anti-Microbial Resistance Congress 2017
    Andrew McCandlish
    Director, Corporate Development
    Achaogen
    Clive Meanwell at World Anti-Microbial Resistance Congress 2017
    Clive Meanwell
    Chief Executive Officer
    The Medicines Company
    Tyler Merkeley at World Anti-Microbial Resistance Congress 2017
    Tyler Merkeley
    Program Manager
    CARB-X
  • Pierre Meulien at World Anti-Microbial Resistance Congress 2017
    Pierre Meulien
    Executive Director of Innovative Medicines Initiative
    Innovative Medicines Initiative
    Gareth Morgan at World Anti-Microbial Resistance Congress 2017
    Gareth Morgan
    Senior Vice President, Global Portfolio Management
    Shionogi Inc
    Jason Newland at World Anti-Microbial Resistance Congress 2017
    Jason Newland
    Director of Antimicrobial Stewardship Program
    Washington University in St. Louis
  • Jean Patel at World Anti-Microbial Resistance Congress 2017
    Jean Patel
    Deputy Director, Office of Antimicrobial Resistance
    Center for Disease Control & Prevention
    David Paterson at World Anti-Microbial Resistance Congress 2017
    David Paterson
    Professor Of Medicine
    University Of Queensland Centre For Clinical Research
    Manos Perros at World Anti-Microbial Resistance Congress 2017
    Manos Perros
    President & CEO
    Entasis Therapeutics
  • Yannick Pletan at World Anti-Microbial Resistance Congress 2017
    Yannick Pletan
    Senior Consultant
    ULTRACE
    Aleks Radovic-Moreno at World Anti-Microbial Resistance Congress 2017
    Aleks Radovic-Moreno
    Senior Associate
    PureTech Health
    Jeffrey Riley at World Anti-Microbial Resistance Congress 2017
    Jeffrey Riley
    Chief Executive Officer, Director and President
    Synthetic Biologics
  • Ribhi Shawar at World Anti-Microbial Resistance Congress 2017
    Ribhi Shawar
    Branch Chief, Division of Microbiology
    CDRH OIR FDA
    Jeff Stein at World Anti-Microbial Resistance Congress 2017
    Jeff Stein
    President and Chief Executive Officer
    Cidara Therapeutics
    Melissa Stundick at World Anti-Microbial Resistance Congress 2017
    Melissa Stundick
    Head of Strategic Alliances
    Spero Therapeutics LLC
  • Dolca Thomas at World Anti-Microbial Resistance Congress 2017
    Dolca Thomas
    Vice President and Head of Translational Medicine for Immunology and Inflammation and Infectious Disease
    Roche
    David Visi at World Anti-Microbial Resistance Congress 2017
    David Visi
    Senior Associate, Antibiotic Resistance Project
    The Pew Charitable Trusts
    Bernhardt Zeiher at World Anti-Microbial Resistance Congress 2017
    Bernhardt Zeiher
    President, Global Development
    Astellas Pharma Global Development Inc
  • Zachary Zimmerman at World Anti-Microbial Resistance Congress 2017
    Zachary Zimmerman
    CEO
    Forge Therapeutics
    Janet Hammond at World Anti-Microbial Resistance Congress 2017
    Janet Hammond
    Vice President Infectious Diseases
    AbbVie
    Christopher Jones at World Anti-Microbial Resistance Congress 2017
    Christopher Jones
    Acting Associate Deputy Assistant Secretary
    U.S. Department of Health & Human Services
  • Deborah O'Neil at World Anti-Microbial Resistance Congress 2017
    Deborah O'Neil
    Chief Executive & Scientific Officer
    NovaBiotics Ltd
    Erik Paulsen at World Anti-Microbial Resistance Congress 2017
    Erik Paulsen
    Congressman
    United States House Of Representatives
    David Payne at World Anti-Microbial Resistance Congress 2017
    David Payne
    VP Antibacterial Discovery Performance Unit
    GlaxoSmithKline
  • William Powderly at World Anti-Microbial Resistance Congress 2017
    William Powderly
    President
    Infectious Diseases Society of America
    Susan Sharp at World Anti-Microbial Resistance Congress 2017
    Susan Sharp
    Past President
    American Society For Microbiology
    Brad Spellberg at World Anti-Microbial Resistance Congress 2017
    Brad Spellberg
    Chief Medical Officer
    Keck School of Medicine of U.S.C.
  • Chris Stevens at World Anti-Microbial Resistance Congress 2017
    Chris Stevens
    Chief Medical Officer
    Arsanis Inc
    Daniel Uslan at World Anti-Microbial Resistance Congress 2017
    Daniel Uslan
    Director, Antimicrobial Stewardship Program, Division of Infectious Diseases
    U.C.L.A. Health
    Jeffrey Wager at World Anti-Microbial Resistance Congress 2017
    Jeffrey Wager
    Chairman & CEO
    EnBiotix Inc
  • Jennifer Hoover at World Anti-Microbial Resistance Congress 2017
    Jennifer Hoover
    Chief Scientist, Antibacterial DPU Infectious Disease Therapy Area Unit
    GSK
    Brendan Jackson at World Anti-Microbial Resistance Congress 2017
    Brendan Jackson
    Epidemiology Team Lead, Mycotic Diseases Branch
    C.D.C
    Todd Black at World Anti-Microbial Resistance Congress 2017
    Todd Black
    Executive Director, Infectious Diseases
    Merck Research Laboratory
  • Heather Behanna at World Anti-Microbial Resistance Congress 2017
    Heather Behanna
    Principal
    Sofinnova Ventures
    Kevin Finney at World Anti-Microbial Resistance Congress 2017
    Kevin Finney
    Chief Operating Officer
    Zavante Therapeutics, Inc.
    Joshua Resnick at World Anti-Microbial Resistance Congress 2017
    Joshua Resnick
    Partner
    S.V. Life Sciences
  • Josh Richardson at World Anti-Microbial Resistance Congress 2017
    Josh Richardson
    Managing Director
    Longitude Capital
    Glenn Dale at World Anti-Microbial Resistance Congress 2017
    Glenn Dale
    Head of Early Development, Antimicrobials
    Polyphor Ltd
    Manu Chaudhary at World Anti-Microbial Resistance Congress 2017
    Manu Chaudhary
    Joint Managing Director and Director of Research
    Venus Remedies Ltd
  • Ami Claxton at World Anti-Microbial Resistance Congress 2017
    Ami Claxton
    Global Director, Health Economics and Outcomes Research
    BioMerieux
    Elizabeth Dodds Ashley at World Anti-Microbial Resistance Congress 2017
    Elizabeth Dodds Ashley
    Clinical Pharmacist Duke Antibiotic Stewardship Outreach Network (DASON)
    Duke University
    Oreola Donini at World Anti-Microbial Resistance Congress 2017
    Oreola Donini
    Chief Scientific Officer
    Soligenix
  • Brian Dorsey at World Anti-Microbial Resistance Congress 2017
    Brian Dorsey
    Founding Partner
    Magnasci Ventures
    Barry Eisenstein at World Anti-Microbial Resistance Congress 2017
    Barry Eisenstein
    Chair, Scientific Advisory Board
    CARB-X
    Mark E. Jones at World Anti-Microbial Resistance Congress 2017
    Mark E. Jones
    Head of Project Management
    Basilea Pharmaceutica Ltd
  • Ciara Kennedy at World Anti-Microbial Resistance Congress 2017
    Ciara Kennedy
    Chief Executive Officer
    Amplyx Pharmaceuticals, Inc
    John Kokai-Kun at World Anti-Microbial Resistance Congress 2017
    John Kokai-Kun
    Vice President of Non-Clinical Affairs
    Synthetic Biologics Inc
    Donald Moir at World Anti-Microbial Resistance Congress 2017
    Donald Moir
    Chief Scientific Officer
    Microbiotix Inc
  • Robert P Sambursky at World Anti-Microbial Resistance Congress 2017
    Robert P Sambursky
    Founder, President & Chief Technical/Medical Officer
    Rapid Pathogen Screening, Inc (RPS)
    Monika Schneider at World Anti-Microbial Resistance Congress 2017
    Monika Schneider
    Research Associate, Margolis Center for Health Policy
    Duke University
    Henry Skinner at World Anti-Microbial Resistance Congress 2017
    Henry Skinner
    Managing Director
    Novartis Venture Fund
  • Joseph Sliman at World Anti-Microbial Resistance Congress 2017
    Joseph Sliman
    Senior Vice President, Clinical and Regulatory Affairs
    Synthetic Biologics Inc

 

 

 

DOWNLOAD SPONSORSHIP BROCHURE

 Sponsors

 

Platinum Sponsor

Platinum Sponsor

Gold Sponsor

Gold Sponsor

Associate

Associate

Rapid Pathogen Screening, Inc (RPS) at World Anti-Microbial Resistance Congress 2018

Associate

 

 

DOWNLOAD SPONSORSHIP BROCHURE

2017 ATTENDEES INCLUDED
 

                                                     

GET YOUR PASS NOW

Choose your package

2 DAY CONFERENCE


Individual Pass

USD $2,365

BOOK NOW

 

Group Booking of 3 or more

USD $1,890

BOOK NOW

Venue

Ritz-Carlton
Washington, DC

Conference times

October 25, 2018: 9:00am - 5:00pm
October 26, 2018: 9:00am - 5:00pm